Today: 9 June 2026
Zeta Global Surges 12% After OpenAI Ad Remarks

Zeta Global Surges 12% After OpenAI Ad Remarks

New York, May 18, 2026, 18:02 EDT

Zeta Global Holdings Corp. shares rose 11.6% to finish Monday at $19.19 after CEO David Steinberg said the marketing-tech firm had “executed an agreement” with OpenAI to “help them run their advertising.” Zeta hit $19.44 during the session and barely moved after the close. StockAnalysis

Zeta keeps pushing its AI story this year. The company’s pitch: it’s more than a dashboard facelift—Zeta wants to grab a bigger piece of budget from firms looking to find and hold onto customers.

Zeta jumped in a routine NYSE session, with no holiday schedule in play. The next planned closure is Memorial Day, May 25, 2026, according to the exchange calendar. Zeta outperformed, while the SPDR S&P 500 ETF slipped 0.1% and the Invesco QQQ ETF fell 0.4%.

Zeta shares moved after its May 14 news that it joined Snowflake’s Open Semantic Interchange, which looks to standardize business metrics between companies using open source. The project wants data and AI tools to see and use numbers in the same way. “AI is only as effective as the data it can trust,” Zeta CTO Christian Monberg said. Snowflake’s Josh Klahr said it aims for a “common foundation.” Business Wire

OpenAI already had a foot in the door. Back in January, Zeta said it struck a deal to use OpenAI’s models inside Athena, its enterprise-focused marketing AI agent. “This pushes AI beyond insight and into action,” said OpenAI Chief Commercial Officer Giancarlo Lionetti at the time. Zeta Global

Zeta’s latest results gave the stock a boost. The company posted first-quarter revenue of $396 million, a 50% jump from last year, and upped its 2026 revenue outlook to between $1.779 billion and $1.792 billion. Adjusted EBITDA guidance is now at $396.2 million to $398.4 million for the year. Adjusted EBITDA measures profit before interest, taxes, depreciation and amortization, and cuts out some items.

Zeta CFO Chris Greiner pointed to the company’s run of 19 “beat-and-raise” quarters as “evidence of sustained demand.” CEO David Steinberg said Athena saw over seven times more agent interactions in its first week after launch. That’s been a number investors have focused on when weighing whether Athena can drive higher usage and spending. Business Wire

Zeta is still facing tough competition. Speaking at the J.P. Morgan conference, Steinberg compared Zeta to Salesforce, Adobe, and The Trade Desk, saying Zeta wants to take on point solutions in marketing. That’s a heavy lift. If growth slows, the market may not be kind to that kind of pitch.

Ad-data stocks were active. Shares of LiveRamp jumped after Publicis said it will acquire the U.S. data-collaboration firm in an enterprise value deal worth about $2.2 billion. The move shows agencies and marketing tech are still putting money down for data as they bet it will count for AI ad targeting.

Zeta has some big risks lined up. The company still needs to prove out the economics of the OpenAI ad comments, keep Athena adoption growing, and protect margins if more sales show up from lower-margin integrated channels. In its latest 10-Q, Zeta says its growth relies on bringing in and holding large “super-scaled” customers. The filing also warns that competition or bad calls on product investment could weigh on results. Securities and Exchange Commission

Investors put the upside trade back in play on Monday. The question is whether Zeta can turn the OpenAI and Snowflake storylines into real reported revenue instead of just more AI headlines.

Stock Market Today

  • Wheat Futures Rise as Export Inspections Show Mixed Data
    June 9, 2026, 9:19 AM EDT. Wheat futures gained on Monday, with Chicago SRW up 5-7 cents, KC HRW up 9-11 cents, and MPLS spring wheat rising slightly. Export inspections reported 319,730 MT shipped in the week ending June 4, down 20.65% from the previous week and 1.38% below last year. Mexico led exports with 83,211 MT. Managed money increased net shorts in Chicago wheat futures to 57,871 contracts, hitting a record bear move since 2006. Ukraine's wheat crop estimate rose 1.8 MMT to 21.7 MMT. July 26 CBOT Wheat futures closed at $5.86 ½, up 6 ½ cents, reflecting bullish momentum amid volatile trading conditions.

Latest articles

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

GSK’s $10.6 Billion Oncology Leap Goes Deeper Than Headlines Show

9 June 2026
GSK will buy Nuvalent for $10.6 billion in cash, paying a 40% premium, to boost its oncology pipeline ahead of looming HIV drug patent expiries; Nuvalent shares jumped 38.9% premarket while GSK fell 1.4%, with the deal expected to add to GSK sales and profit from 2027 but dilute earnings per share 2026-2028 if it closes in Q3, and final outcome depends on FDA approvals and regulatory clearance.
AmpliTech’s 5G Radio Test Moves AMPG Shares

AmpliTech’s 5G Radio Test Moves AMPG Shares

9 June 2026
AMPG soared 26.7% to $6.57 after AmpliTech revealed its 64T64R Massive MIMO radio was the only one of its kind at O-RAN PlugFest, showing interoperability with major carriers’ equipment, but no new orders were announced, leaving sales conversion as the key investor focus.
Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

Cartesian Growth Ticker Change Draws Trader Attention to Factorial Energy

9 June 2026
Factorial Energy surged 16% to $13.80 in its Nasdaq debut as FAC, with premarket trading near $20.70, after replacing CGCT via SPAC merger that raised over $100 million for battery commercialization and implied a $1.3 billion equity value; former CGCT shares now trade as FAC, with founders retaining majority voting power and staged lock-up releases ahead.
Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

Pfizer Falls in Premarket; Fresh FDA Approval Not Lifting the Stock

9 June 2026
Pfizer shares fell 1.7% premarket to $25.62 as investors weighed an FDA label expansion for hemophilia drug Hympavzi—now the first subcutaneous non-factor therapy for children 6-11 with hemophilia B—against slower progress in obesity drugs, with mid-stage data for weight-loss shot berobenatide showing a 23.3% vomiting rate and no immediate growth catalyst for the $147 billion company.
Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

Snap Shares Fall Even as Nasdaq Gains; June 16 in Focus

9 June 2026
Snap Inc. shares fell 1.9% to $5.65, underperforming a rising Nasdaq and leaving the stock 46% below its 52-week high, as investors weigh weak ad revenue growth, North American user declines, and cost-cutting moves against ongoing competitive pressure from Meta and TikTok.
ServiceNow Jumps After Wall Street Shifts AI View
Previous Story

ServiceNow Jumps After Wall Street Shifts AI View

Wall Street Feels the Heat (and Thrill): Fed Cuts, Tariffs & Mega-Mergers Set NYSE Buzz
Next Story

US Stock Market Today: Live Updates 19.05.2026

Go toTop